Article
Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers.
Breast cancer research and treatment - 1 Jan 2014
Tsang Julia Y S, Hui Suen-Wah, Ni Yun-Bi, Chan Siu-Ki, Yamaguchi Rin, Kwong Ava, Law Bonita K B, Tse Gary M
Abstract excerpt
The value for lymphocytic infiltration (LI) has been increasingly recognized for tumor assessment. In breast cancer, however, the overall significance of LI remains poorly defined, probably due to its heterogeneity. A large cohort of breast cancer was evaluated for the degree of LI and its association with traditional pathologic factors, biomarker expression, and cancer subtypes. The number of CD8 cytotoxic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.